More than 500 new bio/pharma products will be launched in 2017 and as executing a comprehensive launch becomes increasingly more complex, it is critical to understand key items when mapping your product plan. A pharmaceutical product launch is one of the most critical moments in a product lifecycle. As the regulatory and commercial environments constantly evolve, it is vital to the success of an organization to adapt new launch strategies and tailor a launch to each product.

CBI’s Bio/Pharma Product Launch Summit is a can\’t-miss opportunity to discuss with innovative peers how to successfully launch a product in a highly saturated market and navigate the road map to consumer relevance and commercial success.

CAPITALIZE ON 10 CRITICAL REASONS TO ATTEND:

• Evaluate the difference for launching a rare disease drug, biosimilar or specialty drug
• Recognize the payer’s expectations to ensure product reimbursement
• Optimize the commercial infrastructure to support a successful launch
• Enhance product launch team resources to align, communicate and collaborate more effectively
• Navigate the complexities of accurate forecasting
• Differentiate a product to gain competitive advantage in the market
• Utilize data analytics to track drug prescription trends and implement the key takeaways into the pre- and post- launch strategy
• Develop trade marketing materials to successfully create the trade “value proposition”
• Create a clear, concise communication platform for a drug candidate to improve performance
• Take a deep dive into the customer engagement model and how it’s evolving rapidly with technology